We specialize in the production of high quality antibodies at industry-leading speeds. Our HTP™ platform allows for product delivery in just 2-3 months, saving our customers time and money. We utilize a genetically engineered mouse, parallel automated processes and proprietary technology to consistently outperform the market.
- High speed
- High affinity
- Broad epitope diversity
- Proven track record
- Ability to make antibodies to difficult targets
What is the HTP™ Platform?
The HTP™ Platform is Abpro’s proprietary high-speed murine hybridoma production platform. The HTP™ Platform generates hybridomas in 40 days and delivers monoclonal cell lines specific to your antigen in 40-60 days. The HTP™ Platform is also capable of generating antibodies to targets that are traditionally difficult such as anti-idiotype and high homology targets.
How Does the HTP™ Platform Work?
At the core of the HTP™ Platform is our proprietary mouse. Abpro’s HTP™ mouse has a boosted immune system which displays a broader epitope spread than any other strain of mouse. The HTP™ mouse, combined with our optimized protocols, experienced scientists, and state-of-the-art lab equipment, allows Abpro to make highly specific and functional antibodies in less than half the time of conventional methods.
How Was the HTP™ Platform Developed?
Abpro’s founders examined the research environment and identified a bottleneck caused by a lack of quality reagents, specifically antibodies. Because the classic antibody production process relies heavily on the immune system of a mouse to develop B-cells specific to the antigen, they set out to engineer a mouse that would optimize the monoclonal antibody development process. They were successful; we call their breakthrough the ‘HTP™ Mouse’.
What Types of Projects are Best for the HTP™ Platform?
We recommend the HTP™ Platform to develop anything from therapeutic candidates to reagent antibodies. Any time a quality antibody needs to be made right the first time, use the HTP™ platform.